Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Bagnato

Showing results (41-50 of 90) with videos related to

Pageof 9
Sort By:
Life Sciences|January 19, 2016
Macitentan blocks endothelin-1 receptor activation required for chemoresistant ovarian cancer cell plasticity and metastasisRosanna Sestito, Roberta Cianfrocca, Laura Rosanò, et al.
Life Sciences|March 11, 2014
Endothelin-1 regulates hypoxia-inducible factor-1α and -2α stability through prolyl hydroxylase domain 2 inhibition in human lymphatic endothelial cellsValentina Caprara, Silvia Scappa, Emirena Garrafa, et al.
Oncotarget|February 25, 2016
Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progressionRoberta Cianfrocca, Piera Tocci, Laura Rosanò, et al.
Cancer Letters|August 30, 2020
Endothelin-1 axis fosters YAP-induced chemotherapy escape in ovarian cancerPiera Tocci, Roberta Cianfrocca, Rosanna Sestito, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cellsFrancesca Spinella, Laura Rosanò, Valeriana Di Castro, et al.
Molecular Cancer Therapeutics|July 11, 2007
ZD4054, a specific antagonist of the endothelin A receptor, inhibits tumor growth and enhances paclitaxel activity in human ovarian carcinoma in vitro and in vivoLaura Rosanò, Valeriana Di Castro, Francesca Spinella, et al.
Life Sciences|January 19, 2016
Endothelin-1/endothelin A receptor axis activates RhoA GTPase in epithelial ovarian cancerPiera Tocci, Valentina Caprara, Roberta Cianfrocca, et al.
Life Sciences|February 18, 2014
β-Arrestin 1 is required for endothelin-1-induced NF-κB activation in ovarian cancer cellsRoberta Cianfrocca, Piera Tocci, Elisa Semprucci, et al.
Clinical Science (London, England : 1979)|August 24, 2002
Endothelin-1 acts as a survival factor in ovarian carcinoma cellsDonatella Del Bufalo, Valeriana Di Castro, Annamaria Biroccio, et al.
Clinical Science (London, England : 1979)|August 24, 2002
Endothelin receptor blockade inhibits the growth of human papillomavirus-associated cervical carcinomaAldo Venuti, Debora Salani, Alessia Cirilli, et al.
Pageof 9

Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
Life Sciences|January 19, 2016
Macitentan blocks endothelin-1 receptor activation required for chemoresistant ovarian cancer cell plasticity and metastasisRosanna Sestito, Roberta Cianfrocca, Laura Rosanò, et al.
Life Sciences|March 11, 2014
Endothelin-1 regulates hypoxia-inducible factor-1α and -2α stability through prolyl hydroxylase domain 2 inhibition in human lymphatic endothelial cellsValentina Caprara, Silvia Scappa, Emirena Garrafa, et al.
Oncotarget|February 25, 2016
Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progressionRoberta Cianfrocca, Piera Tocci, Laura Rosanò, et al.
Cancer Letters|August 30, 2020
Endothelin-1 axis fosters YAP-induced chemotherapy escape in ovarian cancerPiera Tocci, Roberta Cianfrocca, Rosanna Sestito, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cellsFrancesca Spinella, Laura Rosanò, Valeriana Di Castro, et al.
Molecular Cancer Therapeutics|July 11, 2007
ZD4054, a specific antagonist of the endothelin A receptor, inhibits tumor growth and enhances paclitaxel activity in human ovarian carcinoma in vitro and in vivoLaura Rosanò, Valeriana Di Castro, Francesca Spinella, et al.
Life Sciences|January 19, 2016
Endothelin-1/endothelin A receptor axis activates RhoA GTPase in epithelial ovarian cancerPiera Tocci, Valentina Caprara, Roberta Cianfrocca, et al.
Life Sciences|February 18, 2014
β-Arrestin 1 is required for endothelin-1-induced NF-κB activation in ovarian cancer cellsRoberta Cianfrocca, Piera Tocci, Elisa Semprucci, et al.
Clinical Science (London, England : 1979)|August 24, 2002
Endothelin-1 acts as a survival factor in ovarian carcinoma cellsDonatella Del Bufalo, Valeriana Di Castro, Annamaria Biroccio, et al.
Clinical Science (London, England : 1979)|August 24, 2002
Endothelin receptor blockade inhibits the growth of human papillomavirus-associated cervical carcinomaAldo Venuti, Debora Salani, Alessia Cirilli, et al.
Pageof 9